Therapies, Investigational

"Therapies, Investigational" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Treatments which are undergoing clinical trials or for which there is insufficient evidence to determine their effects on health outcomes; coverage for such treatments is often denied by health insurers.

Descriptor ID	D035703
MeSH Number(s)	E02.931
Concept/Terms	Therapies, Investigational Therapies, Investigational Investigational Therapy Therapy, Investigational Investigational Treatments Investigational Treatment Treatment, Investigational Treatments, Investigational Experimental Therapies Experimental Therapy Therapies, Experimental Therapy, Experimental Investigational Therapies Innovative Therapies Innovative Therapies Innovative Therapy Therapies, Innovative Therapy, Innovative

Below are MeSH descriptors whose meaning is more general than "Therapies, Investigational".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Therapies, Investigational [E02.931]

Below are MeSH descriptors whose meaning is related to "Therapies, Investigational".

Below are MeSH descriptors whose meaning is more specific than "Therapies, Investigational".

Therapies, Investigational
Compassionate Use Trials

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Therapies, Investigational" by people in this website by year, and whether "Therapies, Investigational" was a major or minor topic of these publications.

Bar chart showing 17 publications over 10 distinct years, with a maximum of 4 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2011	0	1	1
2012	2	0	2
2015	1	0	1
2016	1	0	1
2017	2	2	4
2018	2	0	2
2020	0	1	1
2021	1	1	2
2022	0	2	2
2024	0	1	1

Below are the most recent publications written about "Therapies, Investigational" by people in Profiles.

Ago Y, Rintz E, Musini KS, Ma Z, Tomatsu S. Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy. Int J Mol Sci. 2024 Jan 17; 25(2).

View in: PubMed
Narasimhan B, Aggarwal D, Satish P, Kantharia B, Aronow WS. Postural orthostatic tachycardia syndrome: pathophysiology, management, and experimental therapies. Expert Opin Investig Drugs. 2022 Oct; 31(10):1017-1025.

View in: PubMed
O'Laughlin KN, Thompson M, Hota B, Gottlieb M, Plumb ID, Chang AM, Wisk LE, Hall AJ, Wang RC, Spatz ES, Stephens KA, Huebinger RM, McDonald SA, Venkatesh A, Gentile N, Slovis BH, Hill M, Saydah S, Idris AH, Rodriguez R, Krumholz HM, Elmore JG, Weinstein RA, Nichol G. Study protocol for the Innovative Support for Patients with SARS-COV-2 Infections Registry (INSPIRE): A longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection. PLoS One. 2022; 17(3):e0264260.

View in: PubMed
Pazzi C, Farrehi C, Capron M, Anderson K, Richardson B, Stillman M. An Assessment of Which Sociodemographic and Spinal Cord Injury-Specific Characteristics Influence Engagement With Experimental Therapies and Participation in Clinical Trials. Top Spinal Cord Inj Rehabil. 2021; 27(4):28-39.

View in: PubMed
Hou PC, Wang HT, Abhee S, Tu WT, McGrath JA, Hsu CK. Investigational Treatments for Epidermolysis Bullosa. Am J Clin Dermatol. 2021 Nov; 22(6):801-817.

View in: PubMed
Farrehi C, Pazzi C, Capron M, Anderson K, Richardson B, Stillman M. How individuals with spinal cord injury in the United States access and assess information about experimental therapies and clinical trials: results of a clinical survey. Spinal Cord Ser Cases. 2020 11 23; 6(1):103.

View in: PubMed
Bavaria JE. Quality and Innovation in Cardiothoracic Surgery: Colliding Imperatives? Ann Thorac Surg. 2018 11; 106(5):1276-1282.

View in: PubMed
Prinzen FW, Dagres N, Bollmann A, Arnar DO, Bove S, Camm J, Casadei B, Kirchhof P, Kuck KH, Lumens J, Michel MC, Schwartz PJ, Van Vleymen B, Vardas P, Hindricks G. Innovation in cardiovascular disease in Europe with focus on arrhythmias: current status, opportunities, roadblocks, and the role of multiple stakeholders. Europace. 2018 05 01; 20(5):733-738.

View in: PubMed
Altit R, Gray WA. New Innovations in Drug-Eluting Stents for Peripheral Arterial Disease. Curr Cardiol Rep. 2017 10 12; 19(11):117.

View in: PubMed
Reilly KM, Kim A, Blakely J, Ferner RE, Gutmann DH, Legius E, Miettinen MM, Randall RL, Ratner N, Jumb? NL, Bakker A, Viskochil D, Widemann BC, Stewart DR. Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future. J Natl Cancer Inst. 2017 08 01; 109(8).

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement